| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/31/2008 | WO2008014401A2 Methods for identifying modulators of rgs21 activity, compositions comprising an rgs21 modulator, and methods of use thereof to modulate taste sensation |
| 01/31/2008 | WO2008014338A2 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 01/31/2008 | WO2008014186A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 01/31/2008 | WO2008012548A1 Linseed extract medicament for application to the eye |
| 01/31/2008 | WO2007126392A8 Antimicrobial peptides |
| 01/31/2008 | WO2007094669A3 Composition used as a nutritional supplement and medication for the treatment of degenerative visual disorders and inflammation |
| 01/31/2008 | WO2007020671B1 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027126 Pyrrolidin-2-One Derivatives for Use as Dp1 Receptor Agonists |
| 01/31/2008 | US20080027121 Novel pyrone-indole derivatives and process for their preparation |
| 01/31/2008 | US20080027120 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 01/31/2008 | US20080027113 Methods of Using and Compositions Comprising Immunomodulatory Compounds for Treatment and Management of Macular Degeneration |
| 01/31/2008 | US20080027108 Therapeutic substituted lactams |
| 01/31/2008 | US20080027100 Functionally selective alpha2C adrenoreceptor agonists |
| 01/31/2008 | US20080027078 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 01/31/2008 | US20080027070 2-amino--5-substituted pyrimidine inhibitors |
| 01/31/2008 | US20080027059 Substituted isoxazolines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/31/2008 | US20080026991 Compositions containing quaternary ammonium compounds |
| 01/31/2008 | US20080026446 Combination of a growth factor and a protease enzyme |
| 01/31/2008 | US20080026033 CHIMERIC AND HUMANIZED ANTIBODIES TO alpha5beta1 INTEGRIN THAT MODULATE ANGIOGENESIS |
| 01/31/2008 | US20080025973 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 01/31/2008 | CA2659055A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 01/31/2008 | CA2658246A1 Monoamine oxidase inhibitors useful for treating disorders of the outer retina |
| 01/31/2008 | CA2657480A1 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 01/31/2008 | CA2657238A1 Compositions and methods for treating or preventing ophthalmic disease |
| 01/30/2008 | EP1882690A2 A process for the preparation of epothilone analogs and intermediates |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1882475A1 Method of treating disorders mediated by the fibroblast growth factor receptor |
| 01/30/2008 | EP1881849A2 Vascular targeting of ocular neovascularization |
| 01/30/2008 | EP1881823A1 Compositions and methods for treatment of eye disorders |
| 01/30/2008 | EP0941125B1 Methods for regulating angiogenesis |
| 01/30/2008 | CN101115728A Triazole substituted aminobenzophenone compounds |
| 01/30/2008 | CN101115489A Diazene-bridged crown ether lithium compounds and methodsfor their use |
| 01/30/2008 | CN101115476A Use of zeaxanthin for the treatment of diseases of the peripheral retina |
| 01/30/2008 | CN101113157A Isoamylene radical chromocor derivative, preparation method and uses thereof |
| 01/30/2008 | CN101112604A Medicine for treating glaucoma and method for preparing the same |
| 01/30/2008 | CN101112534A Chinese traditional medicine compounding for treating diabetes retina pathological changes |
| 01/30/2008 | CN101112500A Chinese traditional medicine composition for treating diabetes retina pathological changes |
| 01/30/2008 | CN101112473A Medicine for treating damp-heat, dizziness, headache, deaf, tinnitus and intra-auricular purulence and method for preparing the same |
| 01/30/2008 | CN101112468A Chinese traditional medicine preparations for treating eyeground hemorrhage vitreous opacity |
| 01/30/2008 | CN101112460A Chinese traditional medicine compounding for treating diabetes retina lesions |
| 01/30/2008 | CN100364599C Oil of aromatic turmeric dripping pills and its preparing process |
| 01/29/2008 | US7323474 Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | US7323463 Combination of brimonidine and timolol for topical ophthalmic use |
| 01/29/2008 | US7323311 Methods of obtaining a specific binding member that binds eotaxin |
| 01/29/2008 | CA2398485C Azalide antibiotic compositions |
| 01/29/2008 | CA2255620C Novel anandamide amidase inhibitors as analgesic agents |
| 01/29/2008 | CA2251982C Ophthalmic compound with extended dwell time on the eye |
| 01/24/2008 | WO2006107902A8 Use of spirostenols to treat mitochondrial disorders |
| 01/24/2008 | US20080021421 Acupoint patch |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/24/2008 | US20080021101 Method Of Preparing A Latanoprost Opthalmic Solution And The Resulting Solution |
| 01/24/2008 | US20080021087 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders |
| 01/24/2008 | US20080021069 Receptor Function Regulating Agent |
| 01/24/2008 | US20080021055 Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/24/2008 | US20080021022 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019977 administering an integrin or integrin subunit antagonist, leukocyte adhesion-inducing cytokine antagonist or growth factor antagonist, a selectin antagonist or adhesion molecule antagonist |
| 01/24/2008 | DE102006034320A1 Antioxidant, useful for preparation of e.g. coloring agent, vesicle, dermocosmetic, pharmaceuticals and nutrient- or feedstuff, comprises at least an isorenieratene compound |
| 01/24/2008 | CA2658764A1 Benzothiophene inhibitors of rho kinase |
| 01/23/2008 | EP1880735A2 Vaccine |
| 01/23/2008 | EP1880213A2 Silver/water, silver gels and silver-based compositions; and methods for making and using the same |
| 01/23/2008 | EP1879590A1 Eslicarbazepine acetate and methods of use |
| 01/23/2008 | EP1879570A2 Inhibition of reactive oxygen species and protection of mammalian cells |
| 01/23/2008 | EP1556354B1 Therapeutic piperazine derivates useful for treating pain |
| 01/23/2008 | EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases |
| 01/23/2008 | EP1490366B1 alkoxypyridine-derivatives |
| 01/23/2008 | EP1366175B1 Multifunctional protease inhibitors and their use in treatment of disease |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | EP1257547B1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP1135498B1 Antibody variants with higher binding affinity compared to parent antibodies |
| 01/23/2008 | CN101111253A Therapeutic agent for eye disease |
| 01/23/2008 | CN101108875A Growth hormone releasing peptides |
| 01/23/2008 | CN101108180A Application of gingkgo lactones B in preparing medicament for preventing and curing retinosis illness |
| 01/23/2008 | CN100362991C Medicine composition for ophthalmology department |
| 01/23/2008 | CN100362990C Fibrauretine-amino acid fluid for transfusion and its production process |
| 01/23/2008 | CN100362989C Ophthalmic composition containing N-acetyl-cysteine for treatment of dry-eye syndrome |
| 01/22/2008 | US7321000 Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320976 Combination of brimonidine and timolol for topical ophthalmic use |
| 01/22/2008 | US7320872 Genetically engineered nervous system cells for use in the treatment of alzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, trauma, brain, muscle, cardiovascular, vision , liver, kidney and pancreas disorders |
| 01/22/2008 | US7320870 Identifying a nucleic acid sequence encoding a lacritin receptor by contacting transfected cells with lacritin and detecting calcium signaling |
| 01/22/2008 | US7320786 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/17/2008 | WO2008008359A2 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 01/17/2008 | WO2008007691A1 Salt of morpholine compound |
| 01/17/2008 | WO2008006235A2 Scfv antibodies which pass epithelial and/or endothelial layers |
| 01/17/2008 | WO2008006168A1 Treatment of excessive neovascularization |
| 01/17/2008 | WO2007048645A3 Protection of oxidizable agents |
| 01/17/2008 | WO2007044668A3 Compstatin and analogs thereof for eye disorders |
| 01/17/2008 | US20080015258 Dissolving moprolol and tartaric acid in a 2:1 molar ratio in ethanol, precipitating and filtering; gels ointments, eyedrops; glaucoma; improved tolerability over hydrochloride salt |
| 01/17/2008 | US20080015255 Pharmaceutical Compositions Based on Fluorinated Sulphamides and Sulphinimides |
| 01/17/2008 | US20080015250 Ultraviolet absorbing ophthalmic compositions |
| 01/17/2008 | US20080015239 For glaucoma or ocular hypertension, irritable bowel disease, and maintenance of colonic mucous |
| 01/17/2008 | US20080015234 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 01/17/2008 | US20080015231 Therapeutic compounds |